Hasibullah Yaqoobi

Hasibullah Yaqoobi

Auto-generated profile, based on publicly available information

Hasibullah Yaqoobi

Department of Infectious Disease and Clinical Microbiology, Başkent University Adana Dr.Turgut Noyan Training and Research Center, Adana, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Medical Mycology
Verified
Journal Article
Open access
ÖGÖzlem Güler
Özlem Güler
MÜMurat Üzel
Murat Üzel
DTDilşat TEPE
Dilşat TEPE
FAFirdevs Aksoy
Firdevs Aksoy
GCGule Cinar
Gule Cinar
ZKZehra Cagla Karakoc
Zehra Cagla Karakoc
This multicentre retrospective study investigated the epidemiology, clinical characteristics, and fluconazole resistance rates of Candida species in osteoarticular infections across Turkey as well as the factors influencing complete recovery. Data were gathered from 73 adult patients diagnosed with proven or probable Candida-associated osteoarticular infections between 2015 and 2025 from 20 healthcare centres. The most common clinical presentation was spondylodiscitis, followed by the involvement of phalangeal bones in the hands and feet. Non-albicans Candida species accounted for 37/73 cases (50.7%), with Candida parapsilosis being the most frequent. Fluconazole resistance was low among Candida albicans isolates (3%) but higher among non-albicans yeasts (27%). Bacterial co-infection, predominantly Gram-positive bacteria, was detected in 52.1% of cases. Diabetes was present in 50/73 patients (68.5%), particularly insulin-dependent diabetes, and was a prominent comorbidity that may have also contributed as a predisposing factor. Radiological detection of osteomyelitis was achieved in 69.9% of patients. Fluconazole was the most commonly used antifungal agent (74%) with a median treatment duration of 90 days. Multivariate analysis revealed that surgical debridement was significantly associated with a higher odds of clinical recovery (adjusted odds ratio [aOR], 5.764; 95% confidence interval [CI], 1.360–24.434; p = 0.017), whereas diabetes mellitus was significantly associated with a lower odds of total recovery (aOR, 0.205; 95% CI, 0.053–0.792; p = 0.022). In conclusion, this multicentre study provides epidemiological data and fluconazole resistance rates of Candida species causing osteoarticular infections in Turkey, highlights the occurrence of C. auris in this cohort, identifies surgical intervention and diabetes mellitus as factors significantly associated with recovery.

30 June 2021 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
OAOğuz Akkuş
Oğuz Akkuş
TBTayibe Bal
Tayibe Bal
HYHasibullah Yagoobi̇
Hasibullah Yagoobi̇
ÖBÖzkan Bekler
Özkan Bekler
GAGamze Akkuş
Gamze Akkuş
MÇMehmet Çabalak
Mehmet Çabalak
Amaç: Bu çalışma ile COVID-19 hastalarında 12-derivasyonlu elektrokardiyografinin (EKG) standart değerlendirmesine ek olarak yeni aritmi belirteçlerini ve tedavi etkisininin araştırılması amaçlanmıştır. Gereç ve Yöntem: Toplam 51 COVID-19 hastasının 12-derivasyonlu EKG si tedavi öncesi, tedavinin 2. ve 5. günlerinde geriye dönük olarak değerlendirildi. Hastalar COVID-19’a yönelik hidroksiklorokin (HCQ) + azitromisin veya sadece HCQ tedavisi aldı. Ciddi COVID-19 hastaları, pnömoni bulgularına ek olarak SpO230/dk olarak tanımlandı. Bulgular: Hastaların %68,6’ı HCQ + azitromisin kombinasyon tedavisi alırken, %31,4 hasta sadece azitromisin tedavisi aldı. Tedavinin 2. gününde, kombinasyon tedavisi alanlarda ve sadece azitromisin alanlarda sadece kalp hızı istatistiksel olarak anlamlı değişken olarak bulundu. Tedavinin 5. gününde kalp hızına ek olarak ve cTpe değerleri her iki tedavi rejiminde istatistiksel olarak anlamlı olarak bulundu. Tedavi süresince her iki tedavi rejiminde Tpe düzeyleri istatistiksel anlamlı olarak artmasına rağmen, rölatif artış oranları istatistiksel olarak gruplar arası benzer bulundu. Sonuç: Çalışma sonuçlarımız, kısa süreli hastanede yatan COVID-19 hastalarında kullandığımız HCQ/ azitromisin tedavisinin kabul edilebilir düzeyde kardiyak etki profiline sahip olduğunu göstermektedir.

10 September 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
SKSibel Yıldız Kaya
Sibel Yıldız Kaya
BKBehice Kurtaran
Behice Kurtaran
NÇNefise Öztoprak Çuvalcı
Nefise Öztoprak Çuvalcı
YÖYusuf Önlen
Yusuf Önlen
Mehmet Reşat CeylanMehmet Reşat Ceylan
Mehmet Reşat Ceylan
HGHep-C Türkiye Study Group
Hep-C Türkiye Study Group
Background/Aims: This study evaluates the efficacy and safety of direct-acting antivirals (DAAs) in treating hepatitis C virus (HCV) genotype 2 (GT-2) and genotype 3 (GT-3) in Türkiye. Materials and Methods: This cohort is a multicenter, retrospective, and observational study. Data from 267 GT-2 or GT-3 patients treated with a DAA were analyzed. Results: An overall sustained virological response (SVR) rate of 95.9%, with no significant difference between GTs. The SVR rates were relatively lower in patients with cirrhosis. Prior pegylated interferon and ribavirin reduced SVR rates, particularly in males and patients with cirrhosis. The most common treatments were sofosbuvir-based regimens, which demonstrated comparable efficacy. No significant drug interactions were observed. The most commonly reported adverse events were fatigue and mild anemia, particularly in cirrhotic patients; however, these did not lead to treatment discontinuation. Conclusion: This study supports the efficacy and tolerability of DAA regimens for these HCV GTs, thereby reinforcing their role in HCV eradication. Cite this article as: Kaya SY, Kurtaran B, Çuvalcı NÖ, et al. Real-life experience of hepatitis C treatment with direct-acting antivirals in genotypes 2 and 3. Turk J Gastroenterol. Published online September 10, 2025. doi: 10.5152/tjg.2025.24751.

26 June 2025 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
HYHasibullah Yaqoobi
Hasibullah Yaqoobi
YDYusuf Ziya Demiroglu
Yusuf Ziya Demiroglu
HAHayriye Altunay
Hayriye Altunay
MHMehmet Ali Habesoglu
Mehmet Ali Habesoglu
TATunzala Asgarova
Tunzala Asgarova
EDEmre Durdag
Emre Durdag
Chronic lymphocytic leukemia (CLL) is characterized by the clonal proliferation of mature-appearing neoplastic B lymphocytes in lymphoid tissues, including peripheral blood, bone marrow, lymph nodes, spleen, and liver. Hypogammaglobulinemia, along with functional impairments in T cells and certain subgroups

15 December 2022 in Mustafa Kemal Üniversitesi Tıp Dergisi
Verified
Journal Article
Closed access
HYHasibullah Yaqoobi̇
Hasibullah Yaqoobi̇
TBTayibe Bal
Tayibe Bal
MÇMehmet Çabalak
Mehmet Çabalak
YÖYusuf Önlen
Yusuf Önlen
SOSabahattin Ocak
Sabahattin Ocak
Nötropenik enterokolit çoğunlukla akut lösemili hastalar gibi mukozal hasarı indükleme potansiyeli yüksek hastalığı olanları ve yoğun kemoterapötik rejimleri alan hastaları etkilemektedir. Burada kemoterapi devamında ateş, karın ağrısı, bulantı, kusma, karında şişkinlik, ishal, ağız içinde yara şikayetleri ile başvuran, batın BT’ de diffüz duodenum duvar kalınlaşması saptanan 34 yaşında akut lenfoblastik lösemi tanılı nötropenik enterokolit olgusu sunulmuştur. Olgumuzu sunmaya değer kılan duodenal bölge tutulumu ile seyreden nötropenik enterokolit olmasıdır.

29 December 2024 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
YDYusuf Ziya Demiroglu
Yusuf Ziya Demiroglu
HAHayriye Altunay
Hayriye Altunay
HYHasibullah Yaqoobi
Hasibullah Yaqoobi
The measles-mumps-rubella (MMR) vaccine is generally considered safe; however, it may occasionally cause adverse effects. This paper presents cases of parotitis, aseptic meningitis, and orchitis that occurred 18-28 days after MMR vaccination in three healthcare workers. All three cases showed mumps IgM seropositivity. While the Leningrad-Zagreb (L-Z) mumps strain present in the MMR vaccine is suspected to be the causative agent, this has not been confirmed molecularly.